SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-052313
Filing Date
2005-11-03
Accepted
2005-11-03 15:48:50
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-17960_110q.htm 10-Q 942060
2 302 CERTIFICATION a05-17960_1ex31d1.htm EX-31.1 12900
3 302 CERTIFICATION a05-17960_1ex31d2.htm EX-31.2 12716
4 906 CERTIFICATION a05-17960_1ex32d1.htm EX-32.1 6345
5 906 CERTIFICATION a05-17960_1ex32d2.htm EX-32.2 7040
  Complete submission text file 0001104659-05-052313.txt   982445
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 051176953
SIC: 2834 Pharmaceutical Preparations